|
May 13
|
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 13
|
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
|
|
May 9
|
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
|
|
Apr 22
|
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
|
|
Apr 2
|
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 8
|
Generation Bio Co Reports Full Year and Q4 2023 Financial Outcomes
|
|
Mar 6
|
Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates
|
|
Mar 6
|
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
|
|
Jan 3
|
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 7
|
Charles Rowland Bought 179% More Shares In Generation Bio
|
|
Dec 6
|
Director Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO)
|
|
Nov 29
|
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
|
|
Nov 9
|
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
|